Publications by authors named "Jing Ping Tang"

Claim this Profile
T
Targeting transcription factors through an IMiD independent zinc finger domain.
Bee Hui Liu, Miao Liu, Sridhar Radhakrishnan, Meng-Yuan Dai, Chaitanya Kumar Jaladanki, Jing Ping Tang

EMBO Mol Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting transcription factors through an IMiD independent zinc finger domain.
Bee Hui Liu, Miao Liu, Sridhar Radhakrishnan, Chaitanya Kumar Jaladanki, Chong Gao, Jing Ping Tang

bioRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SALL4B, not targeted by IMiD, is important for SALL4-mediated tumorigenesis.
Kim Anh L Vu, Kalpana Kumari, Bee Hui Liu, Chong Gao, Feng Li, Jing Ping Tang

bioRxiv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide.
Bee Hui Liu, Chacko Jobichen, C S Brian Chia, Tim Hon Man Chan, Jing Ping Tang

Proc Natl Acad Sci U S A· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcineurin-mediated IL-2 production by CD11cMHCII myeloid cells is crucial for intestinal immune homeostasis.
Andrea Mencarelli, Hanif Javanmard Khameneh, Jan Fric, Maurizio Vacca, Sary El Daker, Jing Ping Tang

Nat Commun· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice.
Ke Guo, Jing Ping Tang, Li Jie, Abdul Qader O Al-Aidaroos, Cheng William Hong

Oncotarget· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting intracellular oncoproteins with antibody therapy or vaccination.
Ke Guo, Jie Li, Jing Ping Tang, Cheng Peow Bobby Tan, Cheng William Hong

Sci Transl Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers.
Jing Ping Tang, Cheng Peow Tan, Jie Li, Md Monowarul Siddique, Ke Guo

Mol Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice.
Ke Guo, Jing Ping Tang, Cheng Peow Bobby Tan, Haihe Wang, Qi Zeng

Cancer Biol Ther· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
Haihe Wang, Samantha Yiling Quah, Jing Ming Dong, Edward Manser, Jing Ping Tang

Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.
Ke Guo, Jie Li, Haihe Wang, Motomi Osato, Jing Ping Tang

Cancer Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
Jie Li, Ke Guo, Vicki Wei Chyi Koh, Jing Ping Tang, Bin Qi Gan

Clin Cancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels.
Ke Guo, Jie Li, Jing Ping Tang, Vicki Koh, Bin Qi Gan

Cancer Biol Ther· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis